Literature DB >> 9639571

Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1.

R C Chambers1, K Dabbagh, R J McAnulty, A J Gray, O P Blanc-Brude, G J Laurent.   

Abstract

Thrombin is a multifunctional serine protease that has a crucial role in blood coagulation. It is also a potent mesenchymal cell mitogen and chemoattractant and might therefore have an important role in the recruitment and local proliferation of mesenchymal cells at sites of tissue injury. We hypothesized that thrombin might also affect the deposition of connective tissue proteins at these sites by directly stimulating fibroblast procollagen production. To address this hypothesis, the effect of thrombin on procollagen production and gene expression by human foetal lung fibroblasts was assessed over 48 h. Thrombin stimulated procollagen production at concentrations of 1 nM and above, with maximal increases of between 60% and 117% at 10 nM thrombin. These effects of thrombin were, at least in part, due to increased steady-state levels of alpha1(I) procollagen mRNA. They could furthermore be reproduced with thrombin receptor-activating peptides for the protease-activated receptor 1 (PAR-1) and were completely abolished when thrombin was rendered proteolytically inactive with the specific inhibitors d-Phe-Pro-ArgCH2Cl and hirudin, indicating that thrombin is mediating these effects via the proteolytic activation of PAR-1. These results suggest that thrombin might influence the deposition of connective tissue proteins during normal wound healing and the development of tissue fibrosis by stimulating fibroblast procollagen production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639571      PMCID: PMC1219564          DOI: 10.1042/bj3330121

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Fibrin seal in wound healing: effect of thrombin and [Ca2+] on human skin fibroblast growth and collagen production.

Authors:  D Michel; M F Harmand
Journal:  J Dermatol Sci       Date:  1990-09       Impact factor: 4.563

2.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

Review 3.  The coagulation cascade: initiation, maintenance, and regulation.

Authors:  E W Davie; K Fujikawa; W Kisiel
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

4.  Thrombin-stimulated events in cultured vascular smooth-muscle cells.

Authors:  B C Berk; M B Taubman; K K Griendling; E J Cragoe; J W Fenton; T A Brock
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

5.  Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells.

Authors:  C J He; E Rondeau; R L Medcalf; R Lacave; W D Schleuning; J D Sraer
Journal:  J Cell Physiol       Date:  1991-01       Impact factor: 6.384

6.  Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides.

Authors:  D H Carney; R Mann; W R Redin; S D Pernia; D Berry; J P Heggers; P G Hayward; M C Robson; J Christie; C Annable
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor.

Authors:  B H Chao; S Kalkunte; J M Maraganore; S R Stone
Journal:  Biochemistry       Date:  1992-07-14       Impact factor: 3.162

8.  Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.

Authors:  I J Sarembock; S D Gertz; L W Gimple; R M Owen; E R Powers; W C Roberts
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

9.  Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action.

Authors:  R Bar-Shavit; M Benezra; A Eldor; E Hy-Am; J W Fenton; G D Wilner; I Vlodavsky
Journal:  Cell Regul       Date:  1990-05

10.  An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion.

Authors:  R Bar-Shavit; V Sabbah; M G Lampugnani; P C Marchisio; J W Fenton; I Vlodavsky; E Dejana
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

View more
  52 in total

Review 1.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

Review 3.  Mechanisms of alveolar epithelial injury, repair, and fibrosis.

Authors:  Rachel C Chambers; Paul F Mercer
Journal:  Ann Am Thorac Soc       Date:  2015-03

Review 4.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

5.  Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.

Authors:  Galina S Bogatkevich; Anna Ludwicka-Bradley; Richard M Silver
Journal:  Arthritis Rheum       Date:  2009-11

Review 6.  Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.

Authors:  Tanjina Akter; Richard M Silver; Galina S Bogatkevich
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

7.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

8.  Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN2/CTGF expression.

Authors:  Samuel A Black; Philip C Trackman
Journal:  J Biol Chem       Date:  2008-02-20       Impact factor: 5.157

9.  Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain.

Authors:  Eric S Mullins; Keith W Kombrinck; Kathryn E Talmage; Maureen A Shaw; David P Witte; Joni M Ullman; Sandra J Degen; William Sun; Matthew J Flick; Jay L Degen
Journal:  Blood       Date:  2008-10-16       Impact factor: 22.113

10.  Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS).

Authors:  Malgorzata Wygrecka; Philipp Markart; Ludger Fink; Andreas Guenther; Klaus T Preissner
Journal:  Thorax       Date:  2007-05-04       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.